Omega-3 fatty acid supplementation attenuates oxidative stress, inflammation, and tubulointerstitial fibrosis in the remnant kidney
about
Mitochondria: a new therapeutic target in chronic kidney diseaseOmega-3s and cardiovascular health.How the kidney is impacted by the perinatal maternal environment to develop hypertensionThe ω-3 polyunsaturated fatty acid, eicosapentaenoic acid, attenuates abdominal aortic aneurysm development via suppression of tissue remodeling.Docosahexaenoic acid inhibits UVB-induced activation of NF-κB and expression of COX-2 and NOX-4 in HR-1 hairless mouse skin by blocking MSK1 signaling.Chronic kidney disease, severe arterial and arteriolar sclerosis and kidney neoplasia: on the spectrum of kidney involvement in MELAS syndromeChronic kidney disease prediction is an inexact science: The concept of "progressors" and "nonprogressors"Berberine ameliorates chronic kidney injury caused by atherosclerotic renovascular disease through the suppression of NFκB signaling pathway in rats.n-3 Fatty acids block TNF-α-stimulated MCP-1 expression in rat mesangial cells.Effect of Omega-3 Fatty Acid on the Fatty Acid Content of the Erythrocyte Membrane and Proteinuria in Patients with Diabetic Nephropathy.Monoclonal antibody against marinobufagenin reverses cardiac fibrosis in rats with chronic renal failure.Antioxidants in kidney diseases: the impact of bardoxolone methyl.Effect of n-3 fatty acids on the expression of inflammatory genes in THP-1 macrophages.Remnant nephron physiology and the progression of chronic kidney disease.Benefits of omega-3 fatty acid against bone changes in salt-loaded rats: possible role of kidney.L-carnosine alters some hemorheologic and lipid peroxidation parameters in nephrectomized rats.Passive immunization against marinobufagenin attenuates renal fibrosis and improves renal function in experimental renal disease.The Effects of Long-Term Chaetomellic Acid A Administration on Renal Function and Oxidative Stress in a Rat Model of Renal Mass Reduction.Urinary F2 -Isoprostanes in Cats with International Renal Interest Society Stage 1-4 Chronic Kidney Disease.Effects of polyunsaturated fatty acid consumption in diabetic nephropathy.Renoprotection and the Bardoxolone Methyl Story - Is This the Right Way Forward? A Novel View of Renoprotection in CKD Trials: A New Classification Scheme for Renoprotective Agents.Lipotoxicity as a trigger factor of renal disease.Natural antioxidants in the treatment and prevention of diabetic nephropathy; a potential approach that warrants clinical trials.Renal tubular fluid shear stress facilitates monocyte activation toward inflammatory macrophages.Naturally Occurring Compounds: New Potential Weapons against Oxidative Stress in Chronic Kidney Disease.Cardioprotective effects of ω -3 PUFAs in chronic kidney disease.The interaction between ApoA2 -265T>C polymorphism and dietary fatty acids intake on oxidative stress in patients with type 2 diabetes mellitus.Novel Omega-3 Fatty Acid Epoxygenase Metabolite Reduces Kidney Fibrosis.A Study of the Differential Effects of Eicosapentaenoic Acid (EPA) and Docosahexaenoic Acid (DHA) on Gene Expression Profiles of Stimulated Thp-1 Macrophages.Significance of Serum Polyunsaturated Fatty Acid Level Imbalance in Patients with Acute Venous ThromboembolismEicosapentaenoic acid restores diabetic tubular injury through regulating oxidative stress and mitochondrial apoptosis.Different administration schedules of darbepoetin alfa affect oxidized and reduced glutathione levels to a similar extent in 5/6 nephrectomized rats.FTY720 attenuates tubulointerstitial inflammation and fibrosis in subtotally nephrectomized rats.Curcumin and enalapril ameliorate renal failure by antagonizing inflammation in 5/6 nephrectomized rats: role of phospholipase and cyclooxygenase.FTY720 prevents progression of renal fibrosis by inhibiting renal microvasculature endothelial dysfunction in a rat model of chronic kidney disease.Beneficial Effects of 6-Month Supplementation with Omega-3 Acids on Selected Inflammatory Markers in Patients with Chronic Kidney Disease Stages 1-3.Erlotinib attenuates the progression of chronic kidney disease in rats with remnant kidney.Nitraria retusa fruit prevents penconazole-induced kidney injury in adult rats through modulation of oxidative stress and histopathological changes.Dietary flaxseed oil and fish oil ameliorates renal oxidative stress, protein glycation, and inflammation in streptozotocin-nicotinamide-induced diabetic rats.Urinary vimentin mRNA as a potential novel biomarker of renal fibrosis.
P2860
Q26776397-F2B4D5F7-D0A4-421D-AB4A-1677CB8BEC90Q27686781-9DBB71B0-C65E-4A4B-A92A-53A96E50F760Q28389052-2E1E0B3D-1A29-4071-93F1-DB9479351F87Q33567788-F705E549-314B-4A10-99D1-BF837A06969EQ34091232-27649DA3-CB53-42BD-9165-BD3E6FDB33FBQ34165551-C6DD6C4D-2C61-4F13-A698-09F694D75D01Q34367656-2F247B8B-5646-41A1-9E8E-264BBFC80F65Q34652245-2C938C7C-A995-4DC0-903F-CD4D76AA9B01Q34979637-0C0DA6BC-1087-4069-A2D7-7BB016D15206Q35674267-6D8549B2-64FE-4C66-BF43-9065E6B9B30DQ35968905-AD5F3913-4505-4A38-B5CF-C362BEEEE0CDQ36026304-8176D03F-C7F7-48EB-869D-CAA13D66A8BEQ36765533-D84F10AF-0204-4958-AE31-8917064EFD49Q37228467-DDA60015-3D62-4202-8A6C-490FB6B5731AQ37344144-F37CB9E7-DF1B-4EB9-9F09-7703598F784EQ37644637-24E3DEC3-6C0A-4BDC-8343-73FF27DB4BC0Q37644737-DA102FA1-AF29-4EAE-A812-1F21EF762379Q37689808-D0D861D6-F1AE-45A9-8C7D-DC80DFB31291Q37705105-D3D26856-7F35-467A-99E9-5685B9E07052Q37816963-AA1F5CCA-0B46-4CF7-AF09-86A9926988FAQ38107939-936ABA90-BA07-4F54-8EFF-D8F3E5A100C4Q38765934-4FED4238-76E7-4EEF-AA6D-78729FF4E0F0Q39169974-E8D1FE57-1992-4904-960C-4A839B822504Q39379434-DBD83A8E-E41D-454E-8785-71786F18FEC3Q39429579-33720162-AA66-4617-A309-308561C361E7Q40196363-D00854FE-48FC-46C3-B7A9-9519C45BE1FEQ40714647-66C04B8E-DEA0-4103-89E5-0726475343F9Q41981357-262D36FA-3627-41DB-B091-10A897FDD236Q42233437-4ADC579C-9009-4A15-BFDC-C9879E402A00Q42629565-26AABED6-0745-4D0E-B6CE-BAAC631A1DBAQ42906415-A109EF60-EAC2-4CB2-AE0A-9682678F61ACQ43888513-492EFA89-D9A8-4CD4-A930-218E973CAAD3Q44062977-35E85087-F563-43A5-A615-B379587939AAQ44970228-C739FFCD-A617-483E-BE31-33013B9F9F66Q46081929-15BDAB94-3B92-4338-955F-A34337907AABQ48213795-197A6433-168C-4580-9E43-726BF83E2602Q48636743-216DEB2F-9A11-4468-83A3-340AFF5F8F5CQ51004006-3ECE6B5E-0C0F-4061-B5D7-67931FC13BF3Q53129191-B957F7AA-1D33-4125-91F4-5FC9BF6392BFQ53533044-597BF540-74D2-43EE-9D27-EFC94478068C
P2860
Omega-3 fatty acid supplementation attenuates oxidative stress, inflammation, and tubulointerstitial fibrosis in the remnant kidney
description
2009 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2009
@ast
im Oktober 2009 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 2009/10/01)
@sk
vědecký článek publikovaný v roce 2009
@cs
wetenschappelijk artikel (gepubliceerd op 2009/10/01)
@nl
наукова стаття, опублікована в жовтні 2009
@uk
مقالة علمية (نشرت في أكتوبر 2009)
@ar
name
Omega-3 fatty acid supplementa ...... fibrosis in the remnant kidney
@ast
Omega-3 fatty acid supplementa ...... fibrosis in the remnant kidney
@en
Omega-3 fatty acid supplementa ...... fibrosis in the remnant kidney
@nl
type
label
Omega-3 fatty acid supplementa ...... fibrosis in the remnant kidney
@ast
Omega-3 fatty acid supplementa ...... fibrosis in the remnant kidney
@en
Omega-3 fatty acid supplementa ...... fibrosis in the remnant kidney
@nl
prefLabel
Omega-3 fatty acid supplementa ...... fibrosis in the remnant kidney
@ast
Omega-3 fatty acid supplementa ...... fibrosis in the remnant kidney
@en
Omega-3 fatty acid supplementa ...... fibrosis in the remnant kidney
@nl
P2093
P2860
P3181
P1476
Omega-3 fatty acid supplementa ...... fibrosis in the remnant kidney
@en
P2093
Hyun Ju Kim
Kyu-Hyang Cho
Nosratola D. Vaziri
Won Suk An
P2860
P304
P3181
P356
10.1152/AJPRENAL.00217.2009
P577
2009-10-01T00:00:00Z